AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 254.71M | $ 205.49M | $ 195.41M | $ 155.82M | $ 129.83M |
| Gross Profit | $ 110.55M | $ 89.19M | $ 88.27M | $ 72.16M | $ 61.30M |
| Operating Income | $ 24.86M | $ 11.70M | $ 24.23M | $ 18.67M | $ 20.08M |
| EBITDA | $ 28.55M | $ 21.52M | $ 27.72M | $ 20.40M | $ 21.12M |
| Net Income | $ 14.73M | $ 11.96M | $ 15.61M | $ 10.65M | $ 19.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.24M | $ 11.11M | $ 12.04M | $ 4.75M | $ 7.94M |
| Total Assets | $ 217.01M | $ 169.81M | $ 165.26M | $ 148.06M | $ 121.76M |
| Total Debt | $ 54.11M | $ 30.00M | $ 32.19M | $ 38.05M | $ 40.51M |
| Net Debt | $ 43.87M | $ 18.89M | $ 20.15M | $ 33.30M | $ 32.57M |
| Total Liabilities | $ 107.94M | $ 72.74M | $ 77.46M | $ 74.80M | $ 65.02M |
| Stockholders' Equity | $ 110.28M | $ 97.64M | $ 87.80M | $ 73.27M | $ 56.74M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.87M | $ 6.22M | $ 16.02M | $ -173.00K | $ 6.64M |
| Operating Cash Flow | $ -11.75M | $ 13.18M | $ 25.55M | $ 9.00M | $ 12.22M |
| Investing Cash Flow | $ -9.76M | $ -6.95M | $ -9.53M | $ -9.18M | $ -5.58M |
| Financing Cash Flow | $ 11.01M | $ -6.81M | $ -10.63M | $ -6.98M | $ -3.91M |